Shares of Valneva (VALN), a specialty vaccine company closed up over $1.00 per share or almost 19% to close the regular session at $6.67 per ...

Valneva (VALN) announced that the Medicines and Healthcare products Regulatory Agency or MHRA has granted marketing authorization in the United ...

Shares of Valneva (NASDAQ:VALN) traded higher on Wednesday after the French biotech announced that the U.K.’s Medicines and Healthcare Products Regulatory Agency granted marketing authorization for ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...

If authorised, Vimkunya would be the first vaccine in the EU to protect adolescents aged 12 to 17 against Chikungunya.

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old. The virus-like particle (VLP) single-dose chikungunya vaccine is expected to launch in key European markets in ...

The CHMP has requested a post-authorization efficacy study to confirm the effectiveness of Vimkunya in preventing chikungunya in adolescents and adults. The vaccine is expected to launch in Europe ...

SC Weaver is an inventor on a UTMB patent application describing IRES-attenuated alphavirus vaccines ... in the production of this manuscript. Chikungunya virus (CHIKV) causes an acute febrile ...

RNA vaccines are composed of the nucleic acid RNA, which encode antigen genes of an infectious agent. When administered to host cells, the RNA is translated into protein antigens that elicit ...

By Teddy Rosenbluth Robert F. Kennedy Jr. has often trained his criticisms of vaccines on a common ingredient: aluminum, which he has suggested is responsible for a litany of childhood ailments ...